Introduction
Examination of the growth kinetics and morphologic features of fibroblasts cultured from neonatal human skin have demonstrated that these cells are genetically and phenotypically diverse (1) (2) (3) (4) (5) (6) (7) . Examples of clonal heterogeneity in apparently homogeneous connective tissue cell populations have been reported, and it has been suggested that temporal selection of individual cell populations could be involved in cellular remodeling of connective tissues under physiologic conditions (1) (2) (3) (4) (5) (6) (7) (8) (9) . Similar mechanisms could also be involved in pathologic states in which monoclonal or oligoclonal cell populations possessing unfavorable or inappropriate phenotypic features could be selected (10) (11) (12) (13) (14) (15) .
The initial goal ofthese studies was to determine the degree of phenotypic diversity in the pattern of matrix biosynthesis among normal skin fibroblasts. We observed significant differences in the pattern of collagen synthesis in substrains cloned from normal neonatal foreskin. These findings can be accounted for in part, by differential regulation of collagen synthesis at the transcriptional level.
The second goal of our studies was to determine whether heterogeneity also exists in responses involving cell surface receptors for hormones known to affect connective tissue remodeling. We therefore examined the pattern and magnitude of 3'-5'-cAMP responses to PGE2 and PTH. Marked heterogeneity in the cAMP responses to these hormones was also observed, although there was no correlation between the rate of collagen synthesis and the magnitude or pattern of hormone responses. Selective #-mercaptoethanol and fluorography as previously described (18) . Labeled collagens were further characterized by pepsinization at 4°C
followed by SDS-PAGE with or without delayed reduction to distinguish a l(I) from al(III) collagen chains (18, 19 (Table I) . These substrains were, however, responsive to PGE2- Fig. 1 shows the relationship between PTH-and PGE-induced cAMP responses in clones from sample D.W. Although there was a correlation of the PTH and PGE2 responses in substrains from parent culture D.W. (r = 0.77), there was no correlation in the responses to the two hormones in the substrains from parent culture J.R. (not shown). Patterns of responsiveness to PTH and PGE2 remained stable after passage; in general, substrains exhibiting the greatest hormone-induced increases in cAMP levels continued to show enhanced sensitivity to hormonai stimulation. We have previously described an inverse relationship between endogenous PGE2 production and the magnitude ofthe PGE2-induced cAMP response in different human connective tissue cell cultures (28-30). As shown in Fig. 2 , there was no correlation between basal PGE2 levels and the cAMP response to this ligand in the D.W. substrains.
To further investigate the functional heterogeneity of the dermal cells, substrains from the three separate parent cultures were examined for their capacity to synthesize collagen. All substrains produced types I and III collagen (analyzed after pepsinization and resolution of the labeled medium proteins by SDS-PAGE and fluorography), although there was variability in the amount and relative abundance of the individual collagen types. To quantitate the relative capacity ofsubstrains to produce individual procollagens, cells were incubated with [3H]proline, and after separation of the pepsin-resistant me- (2.5 X 106 M). A compares PGE2 production to a1(I) procollagen synthesis. Pepsin-resistent labeled medium proteins were separated by SDS-PAGE. The regions of the gel containing the a 1(I) procollagen bands were excised and counted. Counts have been normalized to DNA content in the culture dishes at the time of labeling. PGE2 production and a1(I) procollagen synthesis were negatively correlated (r = 0.33). B compares a 1(I) procollagen synthesis with the PGE2-induced cAMP responses, which were negatively correlated (r = 0.21).
dium proteins by SDS-PAGE the labeled bands were excised and counted. Fig. 3 shows incorporation of [3H]proline into a 1(I) procollagen in substrains cloned from a single sample of dermis. There was marked heterogeneity in the capacity of the substrains to synthesize a 1(I) procollagen. With passage of the cells the pattern of collagen synthesis among substrains remained stable. There was no correlation between the amounts ofa (I) procollagen synthesized and the production of PGE2 (r = 0.33) (Fig. 3 A) or the magnitude of the PGE2-induced cAMP response (r = 0.21) (Fig. 3 B) .
To determine whether the heterogeneity in collagen synthesis among the substrains was correlated with steady-state levels of procollagen mRNA, cytoplasmic RNA was extracted and hybridized with labeled cDNAs for types I and III procollagen. Northern blot analysis of total RNA demonstrated that there was no cross-hybridization among the probes (data not shown). The levels of procollagen mRNA determined by dot hybridization as a function of the secreted labeled procollagen estimated by [3H]proline incorporation are shown in Fig. 4 . Dot blots were quantitated by scanning with a soft laser densitometer and analyzed with an Apple Ile computer using a Zeineh Videophoresis II electrophoresis reporting program (Biomed Instruments Inc., Fullerton, CA) as previously reported (21). There was a correlation between the steady-state levels of a 1(I) procollagen mRNA and incorporation of [3H]-proline into al(I) collagen chains (r = 0.68). No correlation was found in the pattern of collagen synthesis and hormone responsiveness.
The levels of a I(I) and a2(I) mRNAs were quantitated in substrains from one parent culture (L.T.F.) by scanning the dot blots after hybridization with cDNA probes. The ratios of the a1(I) and a2(I) procollagen mRNAs in the substrains ranged from 1.37 to 2.46. As shown in Fig. 5 , the ratios of a l(I)/a2(I) mRNA were inversely correlated with the ratio of a 1(III)/a I(I) plus a2(I) (type III/type I collagen). Comparison of the levels of types I and III procollagen mRNA (Fig. 6 ) revealed a significant positive correlation (r = 0.86; P < 0.001). The correlation was best between the levels of a I (III) and a2(I) procollagen (r = 0.89; P < 0.001) compared with that of a (III) and al(I)(r= 0.79;P<0.01).
Discussion
We have previously demonstrated that in response to products present in medium conditioned by PBMC, dermal fibroblast populations cultured from different individuals exhibit marked phenotypic diversity in proliferative responses and synthesis of PGE2 and collagenase (1) (2) (3) (4) Type I procollagen mRNA (densitometry units) surements of transcription and mRNA stability are required to establish the molecular basis for heterogeneity in matrix synthetic capacity among substrains.
We previously noted variation in the ratios of levels of a 1(I) and a2(I) procollagen mRNAs in cultured human chondrocytes and synovial fibroblasts ( 19, 21, 22, 34) . These results suggested that the expression of these procollagen genes is not coordinately regulated. We speculated that the excess a2(I) procollagen mRNA was either not translated or the translated product was not secreted by the cells. Similar variation in the ratio of the levels of the a I(I) and ac2(I) procollagen mRNAs was observed among the dermal substrains in the present report, consistent with differential regulation of these two procollagen mRNAs. Furthermore, the results would indicate that the normal ratio of a 1 (I)/a2(I) of 2:1 in parent cultures may reflect the average of constituent populations that vary significantly from this ratio.
Miskulin et al. (25) previously reported that the expression of the type III collagen gene is modulated coordinately with that of the type I collagen genes based on comparison of procollagen mRNA levels in dividing and nondividing cells. In our studies we did not observe a correlation between collagen synthesis and cell doubling times. However, the levels of type III procollagen mRNA were strongly correlated with those of type I (r = 0.86; P < 0.001). This correlation was best between al(III) and a2(I) (r = 0.89; P < 0.001) compared with that between alI(III) and al(I) (r = 0.79; P < 0.01). Our there was a correlation between PGE2 responsiveness and the level of collagen synthesis (22, 34, 40) . We had previously shown that the responsiveness of many different connective tissue cell types (including dermal-, synovial-, and bone-derived cells) to PGE2 is markedly influenced by the levels of endogenous PGE2 (28-30). Treatment of cultured cells with mononuclear cell products such as IL-1/3 or tumor necrosis factor-a, which increased endogenous PGE2 synthesis, resulted in desensitization to PGE2 stimulation. These results were consistent with downregulation of receptors by high ambient levels of PGE2. In the present studies we did not observe a correlation between endogenous levels of PGE2 production and PGE2-induced cAMP responses. Basal unstimulated levels of PGE2 were very low (1.6-7.5 ng/ml) in medium from these cells, however, and based on previous studies with skin and synovial fibroblasts (28, 29) higher levels of PGE2 may be required for receptor downregulation.
We had previously reported that cells cultured from human dermis increase cAMP levels after incubation with PTH (16, 26, 27) . We demonstrated by photoaffinity labeling that the PTH receptor in these cells was similar to that in other PTH target tissues (bone and kidney) (41). Others have confirmed our observations concerning PTH responsiveness in dermal cultures, although the kinetics of PTH binding may differ in skin-and bone-derived cells (42-44). We were interested in examining the cells for responses to PTH, since this hormone may also modulate collagen synthesis (possibly by inducing increases in intracellular cAMP levels) (45, 46) . Our present results indicate that, similar to PGE2, the substrains exhibit marked heterogeneity in their responsiveness to PTH. In fibroblast substrains obtained from one sample, PTH and PGE2 were positively correlated, but this was not observed in substrains from another sample. These results favor heterogeneity in cell surface receptor function rather than a generalized up-or downregulation of adenylate cyclase activity. We have not examined the substrains for the capacity to produce the recently described PTH-related peptide (47) (48) (49) (50) (51) . This ligand does increase cAMP levels in PTH-responsive tissues including dermis, and could potentially downregulate PTH receptors in a manner analogous to endogenous PGE2.
One factor potentially contributing to the heterogeneity in the patterns of collagen synthesis among the substrains could be related to differences in growth rates and the effects of in vitro aging (5, 6) on cell phenotype. This would be relevant to the data in Table I , in which the parent (L.T.F.) was PTH responsive and substrains were unresponsive to this hormone. The parent cells had undergone far fewer doublings in comparison to the clones. However, the stability of substrain phenotype with respect to collagen synthesis and PGE2 response found in these studies and in previous investigations (1-3) argues against aging or senescence as the cause of the phenotypic diversity.
In conclusion, our studies demonstrate that connective tissue cell substrains cloned from normal human dermal tissues are heterogeneous both in terms of synthetic products and in the activity of cell surface receptors for hormones that regulate connective tissue cell function. Selective expansion ofcell populations of connective tissue cells in vivo could give rise to tissues with aberrent patterns of matrix synthesis. In addition, alterations in responses to hormones that regulate these cells could contribute to the disturbance in normal functional activity. Similar processes may also be involved in connective tissue remodeling under physiologic conditions.
